Detalhe da pesquisa
1.
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer.
Semin Cancer Biol
; 77: 127-143, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931951
2.
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Gynecol Oncol
; 156(2): 377-386, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753525
3.
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
Breast Cancer Res Treat
; 174(3): 775-783, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635808
4.
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Gynecol Oncol
; 155(2): 262-269, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31604666
5.
Clinical Development of Anti-mitotic Drugs in Cancer.
Adv Exp Med Biol
; 1002: 125-152, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600785
6.
Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.
Gynecol Oncol
; 132(2): 328-33, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342438
7.
Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.
Gynecol Oncol
; 132(3): 542-50, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462730
8.
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix.
Gynecol Oncol Rep
; 53: 101394, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646445
9.
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Nat Biotechnol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714897
10.
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study.
Swiss Med Wkly
; 153: 40055, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011610
11.
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
Fam Cancer
; 22(3): 283-289, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119509
12.
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.
Ann Transl Med
; 8(24): 1712, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490224
13.
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation.
Gynecol Oncol Rep
; 33: 100600, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613071
14.
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Sci Rep
; 10(1): 19248, 2020 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139817
15.
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Sci Rep
; 10(1): 7073, 2020 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32341426
16.
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor.
Oncogene
; 42(48): 3543-3544, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945747
17.
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.
Clin Cancer Res
; 24(2): 326-333, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084914
18.
High grade serous ovarian carcinomas originate in the fallopian tube.
Nat Commun
; 8(1): 1093, 2017 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061967
19.
Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response.
Crit Rev Oncol Hematol
; 101: 50-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964893